.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer last year for a monstrous $...
.On the heels of a phase 3 gain that fell short to thrill real estate investors, Ironwood Pharmaceut...
.Do not quit Monte Rosa Therapeutics currently. The Boston-based biotech is having a ball after auth...
.Welcome to today's Chutes & Ladders, our summary of notable management hirings, firings and also...
.Commemorating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fi...
.AbbVie has actually returned to the source of its own antipsychotic powerhouse Vraylar searching fo...
.GenSight Biologics is full weeks away from losing money. Again. The biotech simply has adequate cas...
.Monopar Therapies is actually recouping a medication from the scrap heap of AstraZeneca's rare cond...
.With brand new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of exp...
.After developing a genetics treatment alliance along with Dyno Therapeutics in 2020, Roche is back ...